Back to Journals » Infection and Drug Resistance » Volume 12

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

Total article views   HTML views PDF downloads Totals
7,978 Dovepress* 7,422+ 1,669 9,091
PubMed Central* 556 222 778
Totals 7,978 1,891 9,869
*Since 1 April 2019

View citations on PubMed Central and Google Scholar